May 21, 2026, 7:53 AMproactiveinvestors.comAVEFF
Avecho completes treatment phase for Phase III insomnia trial interim analysis
Company announcements
Avecho Biotechnology Ltd (ASX:AVE, OTC:AVEFF, FRA:OEZ) has completed the treatment phase for the final patient required for the planned interim analysis of...